Le Lézard
Classified in: Health, Covid-19 virus
Subjects: MAV, CFG

Media Advisory - Prime Minister's itinerary for Monday, May 25, 2020


OTTAWA, May 24, 2020 /CNW/ -

Note: All times local

Ottawa, Ontario


Private meetings.


The Prime Minister will speak with the President of France, Emmanuel Macron.


The Prime Minister will speak with the Chancellor of Germany, Angela Merkel.



11:15 a.m.

The Prime Minister will address Canadians on the COVID-19 situation, and a media availability will follow.




Rideau Cottage


1 Sussex Drive




Notes for media:




  • Open coverage
  • Media are asked to arrive to the Princess Anne Entrance no later than 10:45 a.m. and to make their way to the P1 Gate once on the grounds.
  • Media wishing to cover the event must be accredited with the Parliamentary Press Gallery.
  • Journalists can dial in to listen and ask questions to the Prime Minister.
  • Participant dial-in numbers:
    Local: 613-960-7527
    Toll-free: 1-888-265-0903
    Pass code: 3418355#


2:00 p.m.

The Prime Minister will attend Question Period.

This document is also available at http://pm.gc.ca

SOURCE Prime Minister's Office


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: